Liminatus Pharma Inc Cl A (LIMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -10,207 | -3,546 |
| Depreciation Amortization | 2 | N/A |
| Other Working Capital | -3,495 | 555 |
| Other Operating Activity | 3,736 | 1,540 |
| Operating Cash Flow | $-9,963 | $-1,451 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -13 | N/A |
| Net Acquisitions | -775 | -2,850 |
| Investing Cash Flow | $-788 | $-2,850 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 4,340 | 3,923 |
| Common Stock Issued | 10,557 | N/A |
| Other Financing Activity | -3,864 | 0 |
| Financing Cash Flow | $11,033 | $3,923 |
| Beginning Cash Position | 56 | 434 |
| End Cash Position | 338 | 56 |
| Net Cash Flow | $281 | $-378 |
| Free Cash Flow | ||
| Operating Cash Flow | -9,963 | -1,451 |
| Capital Expenditure | -13 | N/A |
| Free Cash Flow | -9,976 | -1,451 |